Geneva, Nov. 2 -- International Clinical Trials Registry received information related to the study (ChiCTR2600134693) titled 'Prognostic Study of Primary Cardiac Sarcoma After Treatment' on Oct. 19.

Study Type: Observational study

Study Design: Cohort study

Primary Sponsor: Beijing Cancer Hospital

Condition: primary cardiac sarcoma

Recruitment Status: Not Recruiting

Phase: N/A

Date of First Enrollment: 2026-10-29

Target Sample Size: treatment group:30;

Countries of Recruitment: China

To know more, visit https://www.chictr.org.cn/showproj.html?proj=336192

Disclaimer: Curated by HT Syndication....